NEWSROOM

PRISM MarketView

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

Apr 15, 2025

Feature Details Company Milestones and 2025 Catalysts Across Gene Therapy and Ophthalmic Programs NEW YORK, April 15, 2025 - PRISM MediaWire - PRISM MarketView today published a Q&A feature with Dr. George Magrath, Chief Executive Officer of Opus Genetics, Inc. (“Opus Genetics” or the “Company”) (Nasdaq: IRD), a clinical-stage gene therapy company developing treatments for inherited retinal diseases (IRDs) and broader ophthalmic conditions. Dr. George Magrath, Chief Executive Officer of...

PRISM MarketView Spotlights NextNRG’s Record Growth Amid Surging Energy Demand and AI-Driven Infrastructure Investments

PRISM MarketView Spotlights NextNRG’s Record Growth Amid Surging Energy Demand and AI-Driven Infrastructure Investments

Mar 24, 2025

CEO Michael Farkas Discusses the Company’s Breakout Expansion, Mobile Fueling Success, and Vision for AI/ML-Powered, Decentralized Energy NEW YORK, March 24, 2025 – PRISM MediaWire - PRISM MarketView has released an exclusive interview with Michael Farkas, CEO of NextNRG Inc. (NASDAQ: NXXT), highlighting the company’s record-breaking growth and its role at the forefront of the AI-powered energy revolution. As global demand for decentralized, sustainable, and intelligent energy solutions...

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

Jan 7, 2025

Published Before-and-After Photos Highlight Dramatic Improvements in Netherton Syndrome Patient Treated with QRX003 New York, January 07, 2024 -PRISM MediaWire - PRISM MarketView has released an exclusive interview with Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) CEO Dr. Michael Myers, who shares the company’s notable interim data in its ongoing Netherton Syndrome clinical trials. Quoin, a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, is addressing unmet...

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Nov 13, 2024

Company advancing late-stage clinical programs with novel therapies that target underserved heart diseases NEW YORK, November 13, 2024 - PRISM MediaWire - PRISM MarketView, a leading provider of market insights and company news, proudly announces that Cardiol Therapeutics Inc. (NASDAQ: CRDL, TSX: CRDL) has been added to the PRISM Emerging Biotech Index, which spotlights companies leading innovation and creating market impact within the biotech sector. Cardiol’s focus on anti-inflammatory and...

HUB Security to Present at the 2024 ThinkEquity Conference

HUB Security to Present at the 2024 ThinkEquity Conference

Oct 30, 2024

Tel Aviv, Israel, October 30, 2024 - PRISM MediaWire - HUB Cyber Security Ltd. (NASDAQ: HUBC) ("HUB Security" or the "Company"), a leading provider of cybersecurity solutions and advanced data fabric, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and...

Holder Resources Inc. to Present at the 2024 ThinkEquity Conference

Holder Resources Inc. to Present at the 2024 ThinkEquity Conference

Oct 29, 2024

New York City, New York, Oct. 29, 2024 - PRISM MediaWire - Holder Resources Inc. (“HRI” or “the Company”), a natural resource company with operations in Guyana South America, the fastest growing economy globally, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking...

United States Antimony Corporation to Present at the 2024 ThinkEquity Conference

United States Antimony Corporation to Present at the 2024 ThinkEquity Conference

Oct 29, 2024

Thompson Falls, Montana, October 29, 2024 - PRISM MediaWire - United States Antimony Corporation (“USAC” or the “Company”), (NYSE: UAMY), today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Gary C. Evans, Chairman and co-CEO, will...

IBC Advanced Alloys to Present on October 30 at the 2024 ThinkEquity Conference

IBC Advanced Alloys to Present on October 30 at the 2024 ThinkEquity Conference

Oct 28, 2024

Presentation to be Webcast Live at 11:30 a.m. Eastern New York, New York, October 28, 2024 - PRISM MediaWire - IBC Advanced Alloys (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF), a leading U.S. producer of copper alloy products to defense and commercial markets, announces that it will be participating in the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

Immunophotonics to Present at the 2024 ThinkEquity Conference

Immunophotonics to Present at the 2024 ThinkEquity Conference

Oct 28, 2024

St. Louis, Missouri, October 28, 2024 - PRISM MediaWire - Immunophotonics, Inc. a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial...

Zoomcar to Present at the 2024 ThinkEquity Conference

Zoomcar to Present at the 2024 ThinkEquity Conference

Oct 28, 2024

Bangalore, India, October 28, 2024 - PRISM MediaWire - Zoomcar Holdings, Inc. (“Zoomcar” or the “Company”) (Nasdaq: ZCAR), the Nasdaq-listed leading marketplace for self-drive car sharing, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial...

XTI Aerospace to Present at the ThinkEquity Conference

XTI Aerospace to Present at the ThinkEquity Conference

Oct 24, 2024

ENGLEWOOD, Colo., October 24, 2024 - PRISM MediaWire - XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company") today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. Past ThinkEquity conferences have featured over 70 company presentations, 700+ attendees, and 500+ one-on-one meetings, providing a valuable platform for companies and investors to connect. Scott Pomeroy, Chief Executive Officer of...

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

Oct 24, 2024

EDEN PRAIRIE, Minn., October 24, 2024 - PRISM MediaWire - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...

Sidus Space to Present at the 2024 ThinkEquity Conference

Sidus Space to Present at the 2024 ThinkEquity Conference

Oct 24, 2024

CAPE CANAVERAL, FL, October 24, 2024 - PRISM MediaWire - Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), an innovative, agile space mission enabler, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Carol Craig, CEO, will...

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Oct 24, 2024

Princeton, NJ, October 24, 2024 - PRISM MediaWire - Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Oct 23, 2024

Glen Allen, VA, October 23, 2024 - PRISM MediaWire - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

Oct 23, 2024

MIAMI, FL., October 23, 2024 – PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, (“NRx,” the “Company”) and HOPE Therapeutics, Inc., a medical and technology driven company and wholly-owned subsidiary of NRx, today announced they will be featured as a participating in the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...

Siyata Mobile to Present at The ThinkEquity Conference

Siyata Mobile to Present at The ThinkEquity Conference

Oct 23, 2024

Presentation on October 30 at 4 p.m. ET, and Attend 1x1 Meetings Vancouver, BC, October 23, 2024 - PRISM MediaWire - Siyata Mobile Inc. (Nasdaq: SYTA/SYTAW) (“Siyata” or the “Company”), a global vendor of Push-to-Talk over Cellular (“PoC”) devices and cellular signal booster systems, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...

PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor

PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor

Oct 21, 2024

NEW YORK, October 21, 2024 – PRISM MediaWire - PRISM MarketView is proud to announce its role as the official media sponsor for the upcoming ThinkEquity Conference, a premier event bringing together investors, innovators, and industry leaders. The conference will be held at the Mandarin Oriental New York on Oct. 30, offering an exceptional platform for companies and investors to connect, collaborate and explore emerging opportunities. The ThinkEquity Conference is hosted by ThinkEquity, a...

Innocan Pharma to Present at the 2024 ThinkEquity Conference

Innocan Pharma to Present at the 2024 ThinkEquity Conference

Oct 21, 2024

Herzliya, Israel and Calgary, Alberta, October 21, 2024 - PRISM MediaWire - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry...

Nova Minerals to Highlight Estelle Project Advancements at 2024 ThinkEquity Conference

Nova Minerals to Highlight Estelle Project Advancements at 2024 ThinkEquity Conference

Oct 21, 2024

Management to Present at 8.30-9.00 AM on Wednesday, October 30, 2024, in South Salon I Estelle Project Positioned as a World-Class Gold and Antimony Asset with Multi-Million Ounce Resources Anchorage, Alaska, Oct. 21, 2024 - PRISM MediaWire - Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3), a gold, antimony and critical minerals exploration and development company focused on advancing the Estelle Project in Alaska, will present its latest drill results and...

Pyxis Tankers to Present at the 2024 ThinkEquity Conference

Pyxis Tankers to Present at the 2024 ThinkEquity Conference

Oct 21, 2024

Maroussi, Greece, October 21, 2024 - PRISM MediaWire - Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients and other industry professionals to highlight groundbreaking innovations and financial...

Cyabra to Present at the ThinkEquity Conference in New York City on October 30

Cyabra to Present at the ThinkEquity Conference in New York City on October 30

Oct 21, 2024

New York, NY, October 21, 2024 - PRISM MediaWire - Cyabra Strategy Ltd.(“Cyabra”),a leading provider of an AI-powered solution for combating worldwide disinformation, today announced that Dan Brahmy, Chief Executive Officer and Co-Founder, will present in person at the ThinkEquity Conference in New York, NY, on Wednesday, October 30, 2024, at 12:00pm ET. Management will also hold one-on-one investor meetings on site during that same day. To schedule a meeting, please contact your ThinkEquity...

Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024

Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024

Oct 18, 2024

NEW YORK, October 18, 2024 - PRISM MediaWire - Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company”), a global leader in AI at the convergence of insurance and mobility, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Rohan...

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Oct 18, 2024

NEWTOWN, Pa., Oct. 18, 2024 - PRISM MediaWire - Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it plans to participate in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals...

In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference

In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference

Oct 10, 2024

New York, New York, October 10, 2024 - PRISM MediaWire - PRISM MediaWire - Mental health has not always been a topic to discuss as easily as other health related topics due to the stigma surrounding it. Those who have identified having a mental health condition typically do not seek the proper help or treatment for fear of judgement or admission to being unstable. The reality of it is that whether or not you have a condition, we all need to do things to ensure we have good mental health in the...

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

Sep 25, 2024

NEW YORK, September 25, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO). In this interview, Dr. Chancellor provides insights into the company's latest advancements in urological treatments, particularly in recognition of Urology Awareness Month, and discusses the significant progress made in the development of therapies for hemorrhagic cystitis (HC)....

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Sep 13, 2024

NEW YORK, September 13, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. (Nasdaq: ACON). As a disruptive healthcare technology company focused on chronic low back pain, Aclarion is at the forefront of developing noninvasive tools to help physicians identify the source of pain in spinal discs, potentially revolutionizing the standard of care for this widespread and debilitating condition. Aclarion's Nociscan platform,...

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Aclarion Added to PRISM Emerging Medical Devices Index

Sep 6, 2024

Company's industry-first technology addresses chronic low back pain Aclarion secured its first commercial agreement with Michigan's Sheridan Community Hospital PRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech NEW YORK, September 06, 2024 – PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc. (NASDAQ: ACON) has been added to the PRISM Emerging Medical Devices Index,...

PRISM MarketView Launches AI Infrastructure and Datacenter Index

PRISM MarketView Launches AI Infrastructure and Datacenter Index

Aug 1, 2024

New Index Showcases Companies Positioned to Fuel the Booming AI Market NEW YORK, August 01, 2024-- PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AI Infrastructure and Datacenter Index in response to significant global growth and interest in AI technology. The new PRISM index tracks emerging companies supplying AI-related infrastructure and the datacenters that store this technology. The global AI market...

PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends

PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends

Jul 30, 2024

NEW YORK, NY July 30, 2024 - PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting the traveling consumer as airlines began to announce financial results. Company reports have echoed larger themes related to higher fuel costs, robust travel demand and lower fare discounting driven by competition from low-cost carriers. American Airlines faced a significant decline in profits due in part to an operational decision to make...